Intended for healthcare professionals


In brief

BMJ 2008; 337 doi: (Published 05 November 2008) Cite this as: BMJ 2008;337:a2411

NICE must reveal model used to assess drug for Alzheimer’s: The National Institute for Health and Clinical Excellence has lost the final stage of its legal fight against a court ruling that it must release a copy of the computer model used in its decision to restrict the use of donepezil for Alzheimer’s disease. On 29 October the House of Lords refused to hear a last ditch appeal against a ruling from the Court of Appeal last May that NICE must supply the model to two drug companies that are challenging the refusal to recommend the £2.50 (€3.15; $4) a day drug to NHS patients in …

View Full Text

Log in

Log in through your institution


* For online subscription